These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9611069)

  • 21. Additional case of female monozygotic twins discordant for the clinical manifestations of Duchenne muscular dystrophy due to opposite X-chromosome inactivation.
    Abbadi N; Philippe C; Chery M; Gilgenkrantz H; Tome F; Collin H; Theau D; Recan D; Broux O; Fardeau M
    Am J Med Genet; 1994 Aug; 52(2):198-206. PubMed ID: 7802009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of the CAG repeat polymorphism in the androgen receptor gene and of skewed X-chromosome inactivation, in the pathogenesis of hirsutism.
    Calvo RM; Asunción M; Sancho J; San Millán JL; Escobar-Morreale HF
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1735-40. PubMed ID: 10770223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-skewed X-inactivation may cause mental retardation in a female carrier of X-linked alpha-thalassemia/mental retardation syndrome (ATR-X): X-inactivation study of nine female carriers of ATR-X.
    Wada T; Sugie H; Fukushima Y; Saitoh S
    Am J Med Genet A; 2005 Sep; 138(1):18-20. PubMed ID: 16100724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Skewed X-inactivation in a manifesting carrier of X-linked myotubular myopathy and in her non-manifesting carrier mother.
    Tanner SM; Orstavik KH; Kristiansen M; Lev D; Lerman-Sagie T; Sadeh M; Liechti-Gallati S
    Hum Genet; 1999 Mar; 104(3):249-53. PubMed ID: 10323249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. X inactivation and dystrophin studies in a t(X;12) female: evidence for biochemical normalization in Duchenne muscular dystrophy carriers.
    Wenger SL; Steele MW; Hoffman EP; Barmada MA; Wessel HB
    Am J Med Genet; 1992 Aug; 43(6):1012-5. PubMed ID: 1415326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inheritance of skewed X chromosome inactivation in a large family with an X-linked recessive deafness syndrome.
    Orstavik KH; Orstavik RE; Eiklid K; Tranebjaerg L
    Am J Med Genet; 1996 Jul; 64(1):31-4. PubMed ID: 8826445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CpG dinucleotide methylation patterns in the human androgen receptor gene and X-chromosome inactivation in peripheral blood leukocytes of phenotypically normal women.
    Sato K; Hashiyada M; Uehara S; Nata M; Okamura K
    J Hum Genet; 2003; 48(7):374-9. PubMed ID: 12838396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Duchenne muscular dystrophy manifesting carriers.
    Barkhaus PE; Gilchrist JM
    Arch Neurol; 1989 Jun; 46(6):673-5. PubMed ID: 2730379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of X-chromosome inactivation in symptomatic female carriers of dystrophinopathy.
    Juan-Mateu J; Rodríguez MJ; Nascimento A; Jiménez-Mallebrera C; González-Quereda L; Rivas E; Paradas C; Madruga M; Sánchez-Ayaso P; Jou C; González-Mera L; Munell F; Roig-Quilis M; Rabasa M; Hernández-Lain A; Díaz-Manera J; Gallardo E; Pascual J; Verdura E; Colomer J; Baiget M; Olivé M; Gallano P
    Orphanet J Rare Dis; 2012 Oct; 7():82. PubMed ID: 23092449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic counseling of isolated carriers of Duchenne muscular dystrophy.
    Hoffman EP; Pegoraro E; Scacheri P; Burns RG; Taber JW; Weiss L; Spiro A; Blattner P
    Am J Med Genet; 1996 Jun; 63(4):573-80. PubMed ID: 8826437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determining the role of skewed X-chromosome inactivation in developing muscle symptoms in carriers of Duchenne muscular dystrophy.
    Viggiano E; Ergoli M; Picillo E; Politano L
    Hum Genet; 2016 Jul; 135(7):685-98. PubMed ID: 27098336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Symptomatic carriers of dystrophinopathy with chromosome X inactivation bias].
    Lesca G; Demarquay G; Llense S; Streichenberger N; Petiot P; Michel-Calemard L; Récan D; Vial C; Ollagnon-Roman E
    Rev Neurol (Paris); 2003 Sep; 159(8-9):775-80. PubMed ID: 13679720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In situ hybridization shows direct evidence of skewed X inactivation in one of monozygotic twin females manifesting Duchenne muscular dystrophy.
    Zneimer SM; Schneider NR; Richards CS
    Am J Med Genet; 1993 Mar; 45(5):601-5. PubMed ID: 8456832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. X inactivation as a mechanism of selection against lethal alleles: further investigation of incontinentia pigmenti and X linked lymphoproliferative disease.
    Harris A; Collins J; Vetrie D; Cole C; Bobrow M
    J Med Genet; 1992 Sep; 29(9):608-14. PubMed ID: 1404291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Manifesting carrier of x-linked Duchenne muscular dystrophy.
    Meola G; Scarpini E; Silani V; Scarlato G
    J Neurol Sci; 1981 Mar; 49(3):455-63. PubMed ID: 7217994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absence of correlation between X chromosome inactivation pattern and plasma concentration of factor VIII and factor IX in carriers of haemophilia A and B.
    Orstavik KH; Scheibel E; Ingerslev J; Schwartz M
    Thromb Haemost; 2000 Mar; 83(3):433-7. PubMed ID: 10744150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A survey of manifesting carriers of Duchenne and Becker muscular dystrophy in Wales.
    Norman A; Harper P
    Clin Genet; 1989 Jul; 36(1):31-7. PubMed ID: 2766561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Marked hemiatrophy in carriers of Duchenne muscular dystrophy.
    Rajakulendran S; Kuntzer T; Dunand M; Yau SC; Ashton EJ; Storey H; McCauley J; Abbs S; Thonney F; Leturcq F; Lobrinus JA; Yousry T; Farmer S; Holton JL; Hanna MG
    Arch Neurol; 2010 Apr; 67(4):497-500. PubMed ID: 20385919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. X-linked Duchenne muscular dystrophy in an unusual family with manifesting carriers.
    Kaladhar Reddy B; Anandavalli TE; Reddi OS
    Hum Genet; 1984; 67(4):460-2. PubMed ID: 6490012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between clinical phenotypes and X-inactivation patterns in six female carriers with heterozygote vasopressin type 2 receptor gene mutations.
    Satoh M; Ogikubo S; Yoshizawa-Ogasawara A
    Endocr J; 2008 May; 55(2):277-84. PubMed ID: 18323675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.